Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$513M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$412M |
| 3 |
Meta Platforms (Facebook)
META
|
+$354M |
| 4 |
ServiceNow
NOW
|
+$262M |
| 5 |
American Airlines Group
AAL
|
+$259M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$571M |
| 2 |
Apple
AAPL
|
+$571M |
| 3 |
Netflix
NFLX
|
+$388M |
| 4 |
NVIDIA
NVDA
|
+$313M |
| 5 |
TSMC
TSM
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.32% |
| 2 | Healthcare | 15.28% |
| 3 | Consumer Discretionary | 11.85% |
| 4 | Financials | 11.11% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
SES AI
SES
$196M
| $234K | ﹤0.01% |
450,000
-215,300
| -32% | -$198K |
|
3027
TScan Therapeutics
TCRX
$51.4M
| $234K | ﹤0.01% |
169,706
+159,106
| +1,501% | +$344K |
|
3028
Enliven Therapeutics
ELVN
$4.39B
| $234K | ﹤0.01% |
+11,900
| New | +$256K |
|
3029
iShares ESG Aware MSCI EM ETF
ESGE
$6.72B
| $234K | ﹤0.01% |
6,700
-72,600
| -92% | -$2.53M |
|
3030
First Financial Bankshares
FFIN
$4.96B
| $233K | ﹤0.01% |
+6,500
| New | +$239K |
|
|
IHT
3031
InnSuites Hospitality Trust
IHT
$16.4M
| $233K | ﹤0.01% |
102,903
-1,300
| -1% | -$3.29K |
|
|
AXIA.PR
3032
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
| $232K | ﹤0.01% |
37,631
+18,941
| +101% | +$106K |
|
3033
Biodesix
BDSX
$244M
| $232K | ﹤0.01% |
18,535
+525
| +3% | +$10.1K |
|
|
FPAY
3034
DELISTED
FlexShopper
FPAY
| $231K | ﹤0.01% |
180,778
-102,302
| -36% | -$156K |
|
3035
Avalon Holdings
AWX
$9.9M
| $231K | ﹤0.01% |
81,310
+900
| +1% | +$3.02K |
|
3036
Magyar Bancorp
MGYR
$123M
| $231K | ﹤0.01% |
16,586
| – | – |
|
3037
NextCure
NXTC
$21.8M
| $231K | ﹤0.01% |
39,997
-3,278
| -8% | -$28.9K |
|
3038
VirTra
VTSI
$35.5M
| $230K | ﹤0.01% |
56,597
-51,198
| -47% | -$306K |
|
3039
FNB Corp
FNB
$6.76B
| $229K | ﹤0.01% |
17,027
-245,800
| -94% | -$3.61M |
|
3040
Karyopharm Therapeutics
KPTI
$44.9M
| $229K | ﹤0.01% |
61,214
-18,959
| -24% | -$162K |
|
3041
Daxor
DXR
$59.7M
| $228K | ﹤0.01% |
28,121
+300
| +1% | +$2.35K |
|
3042
Regis Corp
RGS
$71.2M
| $228K | ﹤0.01% |
12,546
-6,100
| -33% | -$133K |
|
3043
Standard Motor Products
SMP
$904M
| $227K | ﹤0.01% |
+9,100
| New | +$267K |
|
3044
Cytosorbents Corp
CTSO
$22.9M
| $225K | ﹤0.01% |
225,254
+137,234
| +156% | +$145K |
|
3045
Custom Truck One Source
CTOS
$2.38B
| $225K | ﹤0.01% |
+53,200
| New | +$257K |
|
|
MKFG
3046
DELISTED
Markforged Holding Corporation
MKFG
| $224K | ﹤0.01% |
47,939
+4,300
| +10% | +$13.1K |
|
|
LX
3047
LexinFintech Holdings
LX
$236M
| $224K | ﹤0.01% |
22,200
-243,500
| -92% | -$2.04M |
|
3048
Orange County Bancorp
OBT
$520M
| $222K | ﹤0.01% |
9,500
-2,700
| -22% | -$69.1K |
|
|
KG
3049
Kestrel Group
KG
$71.4M
| $222K | ﹤0.01% |
19,471
-1,175
| -6% | -$22.2K |
|
3050
Inuvo
INUV
$17.1M
| $221K | ﹤0.01% |
62,325
+11,610
| +23% | +$53.1K |
|
Similar funds
Renaissance Technologies's Q1 2025 Portfolio in Review
As of Q1 2025, Renaissance Technologies held 3,989 positions worth $66.1B, down 2.2% from $67.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2025 filing shows 456 new, 1,472 increased, 1,441 reduced and 583 closed positions. Its largest new stake was ServiceNow: 1,361,505 shares worth $217M. The largest sale was Palantir, an estimated $571M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2025 buy was ServiceNow: 1,361,505 shares worth $217M.
- Renaissance Technologies added most to Broadcom in Q1 2025, an estimated $513M increase.
- Renaissance Technologies's biggest Q1 2025 reduction was Palantir, cutting an estimated $571M.
- Renaissance Technologies fully exited Nike in Q1 2025, selling an estimated $197M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.1B portfolio in Q1 2025.
- Renaissance Technologies opened 456 new positions and closed 583 in Q1 2025.
- Renaissance Technologies's portfolio value fell 2.2% quarter-over-quarter to $66.1B.
Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.